TipRanks

Sorrento Is Firing on All Cylinders

Sorrento Therapeutics (SRNE) is a company with its foot on the gas, and hardly a week goes by without new developments. This week is no different. On Tuesday, the biotech announced a multi-year Cooperative Research and Development Agreement (CRADA) with the U.S. Naval Medical Research Unit (NAMRU-3). The partnership’s aim is to conduct infectious disease research that assists the Department of Defense (DoD), informs host nation partners’ public health policy, and improves the U.S. Armed Forces m

Read More